Adaptive Biotechnologies Corporation Stock
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
19:44:31 02/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 28.17 USD | +2.92% |
|
-4.15% | +73.71% |
| Market Cap | 4.37B 3.88B 3.63B 3.31B 6.22B 421B 6.31B 43.89B 16.99B 214B 16.4B 16.04B 688B | P/E 2026 * |
-50.4x | P/E 2027 * | -164x |
|---|---|---|---|---|---|
| Enterprise Value | 4.2B 3.73B 3.48B 3.18B 5.98B 404B 6.06B 42.15B 16.32B 206B 15.75B 15.41B 661B | EV / Sales 2026 * |
14.3x | EV / Sales 2027 * | 11.6x |
| Free-Float |
97.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
|
Tradegate
| 1HM | Real-time | |
|
Boerse Muenchen
| 1HM | Real-time | |
|
Deutsche Boerse AG
| 1HM | Delayed | |
|
Börse Stuttgart
| 1HM | Delayed |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | +3.47% | ||
| 1 week | -3.81% | ||
| Current month | -2.04% | ||
| 1 month | +14.80% | ||
| 3 months | +33.60% | ||
| 6 months | +91.15% | ||
| Current year | +74.32% |
| 1 week | 27.14 |  | 29.8 |
| 1 month | 23.53 | | 29.96 |
| Current year | 12 | | 29.96 |
| 1 year | 12 | | 29.96 |
| 3 years | 2.28 | | 29.96 |
| 5 years | 2.28 | | 37.55 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 08/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 08/04/2024 |
Julie Rubinstein
PSD | President | 54 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 01/02/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 01/12/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/09/26 | Exercice | Head of Human Resources | 326,526 | 0.2046% | ||
| 15/09/26 | Sell | Executive/Senior Manager | -1,195 | 0.0007% | ||
| 31/08/26 | Don | Director | -12,539 | 0.0079% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.47% | -3.81% | +98.81% | +445.47% | 4.37B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -2.85% | -3.36% | +22.13% | +74.90% | 59.26B | |
| +1.23% | -0.32% | +4.61% | +34.93% | 47.14B | |
| -0.65% | -4.15% | +26.82% | +33.66% | 42.91B | |
| -0.10% | +0.19% | +349.34% | +684.68% | 44.13B | |
| -2.26% | -2.52% | +1.91% | +97.06% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| +0.20% | -7.80% | -28.90% | +328.20% | 23.71B | |
| Average | +0.36% | -1.22% | +56.38% | +186.70% | 39.68B | |
| Weighted average by Cap. | +0.27% | -0.40% | +57.39% | +152.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 261M 244M 222M 418M 28.25B 424M 2.95B 1.14B 14.39B 1.1B 1.08B 46.21B | 359M 319M 298M 272M 512M 34.59B 519M 3.61B 1.4B 17.61B 1.35B 1.32B 56.57B |
| Net income | -85.55M -75.99M -71.06M -64.76M -122M -8.24B -124M -860M -333M -4.19B -321M -314M -13.47B | -26.13M -23.21M -21.71M -19.78M -37.24M -2.52B -37.75M -263M -102M -1.28B -98.12M -96M -4.12B |
| Net Debt | -173M -154M -144M -131M -247M -16.67B -250M -1.74B -673M -8.49B -650M -636M -27.26B | -217M -193M -181M -165M -310M -20.92B -314M -2.18B -845M -10.66B -816M -798M -34.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | $28.15 | +2.85% | 402,344 |
| 01/10/26 | $27.37 | -5.29% | 6,018,788 |
| 30/09/26 | $28.90 | +0.45% | 1,508,275 |
| 29/09/26 | $28.77 | +0.91% | 2,508,234 |
| 28/09/26 | $28.51 | -3.13% | 2,638,957 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
